GSK-112772

Study Sponsor: GSK

Study Title

Follow-up study to evaluate the long-term immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV (580299) vaccine in healthy female subjects

Medicine or Vaccine (generic name)

Human Papillomavirus Types 16 and 18 Vaccine

Sponsor Identification Number

112772

Trial Registry Identification Number(#'s)

NCT00947115 2009-011357-41

Medical Condition

Infections, Papillomavirus

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112772

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00947115

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-011357-41

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. A reporting and analysis plan is not available for this study. The results of this study 112772 are related to103514.

Date Added to this Site

November 2016